Your browser version may not work well with NCBI's Web applications. More information here...
1: Nat Rev Drug Discov. 2006 Dec;5(12):993-6.Click here to read Links

How many drug targets are there?

Overington JP, Al-Lazikani B, Hopkins AL.

Inpharmatica Ltd., 1 New Oxford Street, London, WC1A 1NU, UK. j.overington@inpharmatica.co.uk

For the past decade, the number of molecular targets for approved drugs has been debated. Here, we reconcile apparently contradictory previous reports into a comprehensive survey, and propose a consensus number of current drug targets for all classes of approved therapeutic drugs. One striking feature is the relatively constant historical rate of target innovation (the rate at which drugs against new targets are launched); however, the rate of developing drugs against new families is significantly lower. The recent approval of drugs that target protein kinases highlights two additional trends: an emerging realization of the importance of polypharmacology, and also the power of a gene-family-led approach in generating novel and important therapies.

PMID: 17139284 [PubMed - indexed for MEDLINE]

Recent Activity